Document 0148
 DOCN  M9470148
 TI    Recent advances in the development and use of plasma concentrates.
 DT    9409
 AU    Soutar RL; Aberdeen Royal Infirmary.
 SO    Br J Hosp Med. 1994 Feb 2-15;51(3):119-22. Unique Identifier : AIDSLINE
       MED/94251506
 AB    The consequences of blood donations infected with human immunodeficiency
       virus, the rapid advances in protein fractionation and the introduction
       of recombinant DNA technology have revolutionized the range of plasma
       products available to the clinician. This article reviews these
       developments and describes recent recommendations on their use.
 DE    Blood Coagulation Factors/SUPPLY & DISTRIBUTION/*THERAPEUTIC USE  *DNA,
       Recombinant  Fractionation  Great Britain/EPIDEMIOLOGY
       Hemophilia/COMPLICATIONS/EPIDEMIOLOGY/THERAPY  Human  HIV
       Infections/EPIDEMIOLOGY/ETIOLOGY/PREVENTION & CONTROL  Infection
       Control/*METHODS  Plasma Substitutes/SUPPLY & DISTRIBUTION/*THERAPEUTIC
       USE  Research  JOURNAL ARTICLE  REVIEW  REVIEW, TUTORIAL

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).